Glycemic control and associated factors in patients with type 1 diabetes mellitus in primary care in Southeastern Brazil
DOI:
https://doi.org/10.1590/s2175-97902022e20985Keywords:
Medication adherence, Diabetes, Glycemic control, Knowledge, BrazilAbstract
Diabetes is a self-managed condition with knowledge, attitudes and practices that can influence the overall treatment and outcomes delay the complications of diabetes. However, the few reported studies published point out that: low education level, poor adherence to pharmacotherapy and diet recommendations, infrequent monitoring of blood glucose, and insulin dosage regimen are associated with higher hemoglobin levels. This study aimed to assess the knowledge, adherence medication, and complexity of pharmacotherapy in T1DM patients in Brazil. A cross-sectional study was conducted involving 156 T1DM patients who were attending in primary care. Logistic regression analyses were conducted to assess the variables associated with glycemic control. The overall assessments of T1DM patients for the glycemic control were bad (121, 77.6%). However, T1DM patients with high MedTake Test (OR=2.4, CI=1.1-5.7) and Morisky-Green Test (OR= 2.5, CI=1.1-6.1), and in the use of dosage insulin (>40 units, OR=0.3, CI=0.1-0.7) and postprandial glucose (100-125mg/dl, OR=3.8, CI=1.1-14.6) had better glycemic control compared to uncontrolled patients. Glycemic control in Brazilians adults with T1DM is low. We suggested the screening patients with low MedTake and Morisky-Green Tests, increasing patient knowledge as part of a complex intervention that may lead to substantially improved treatment outcomes in primary care.
Downloads
References
Aikens JE, Piette JD. Longitudinal association between medication compliance and glycaemic control in Type 2 diabetes. Diabet Med. 2013;30(3):338-44.
American Diabetes Association AD. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Supl 1):S55-S64.
Andrade CS, Ribeiro GS, Santos CAST, Neves RCS, Moreira ED. Factors associated with high levels of glycated haemoglobin in patients with type 1 diabetes: a multicentre study in Brazil. BMJ Open. 2017;7(12):e018094.
Angamo MT, Melese BH, Ayen WY. Determinants of glycemic control among insulin treated diabetic patients in Southwest Ethiopia: hospital based cross sectional study. PLoS One. 2013;8(4):e61759.
Ba-Essa EM, Mobarak EI, Alghamdi A, Al-Daghri NM. Intensified glucose selfmonitoring with education in Saudi DM patients. Int J Clin Exp Med. 2015;8(10):19374-80.
Braga de Souza AC, Felício JS, Koury CC, Neto JF, Milléo KB, Santos FM, et al. Health-related quality of life in people with type 1 Diabetes Mellitus: data from the Brazilian Type 1 Diabetes Study Group. Health Qual Life Outcomes. 2015;13:204.
Diaz-Valencia PA, Bougnères P, Valleron AJ. Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health. 2015;15:255.
Farsaei S, Radfar M, Heydari Z, Abbasi F, Qorbani M. Insulin compliance in patients with diabetes: risk factors for injection omission. Prim Care Diabetes. 2014;8(4):338-45.
Fincke BG, Clark JA, Linzer M, Spiro A 3rd, Miller DR, Lee A, et al. Assessment of long-term complications due to type 2 diabetes using patient self-report: the diabetes complications index. J Ambul Care Manag. 2005;28(3):262-273.
Gomes MB, Rodacki M, Pavin EJ, Cobas RA, Felicio JS, Zajdenverg L, et al. The impact of ethnicity, educational and economic status on the prescription of insulin therapeutic regimens and on glycemic control in patients with type 1 diabetes. A nationwide study in Brazil. Diabetes Res Clin Pract. 2017;134:44-52.
Gomes MB, Santos DC, Pizarro MH, Barros BSV, de Melo LGN, Negrato CA. Does knowledge on diabetes management influence glycemic control? A nationwide study in patients with type 1 diabetes in Brazil. Patient Prefer Adherence, 2018;12:53-62.
Gonçalves ACDO, Cazarim MDS, Sanches C, Pereira LRL, Baldoni ADO. How much to invest in glycemic control of a patient with diabetes mellitus type 2? A constant dilemma for the Brazilian Public Health System (SUS). Braz J Pharm Sci. 2019;55:e17197.
International Diabetes Federation. IDF Diabetes Atlas Ninth edition. 2019. https://www.diabetesatlas.org/en/ Accessed 28 Oct 2021.
» https://www.diabetesatlas.org/en/
Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with Type II diabetes. J Diabetes Complicat. 2010;24(2):84-89.
Malta DC, Duncan BB, Schmidt MI, Machado ÍE, Silva AGD, Bernal RTI, et al. Prevalence of diabetes mellitus as determined by glycated hemoglobin in the Brazilian adult population, National Health Survey. Rev Bras Epidemiol. 2019;22:E190006-SUPL.
McCarthy MM, Funk M, Grey M. Cardiovascular health in adults with type 1 diabetes. Prev Med. 2016;91:138-143.
Melchiors AC, Correr CJ, Fernández-Llimos F. Translation and validation into Portuguese language of the medication regimen complexity index. Arq Bras Cardiol. 2007;89(4):210-8.
Mendes AB, Fittipaldi JA, Neves RC, Chacra AR, Moreira ED. Prevalence and correlates of inadequate glycaemic control: results from a nationwide survey in 6,671 adults with diabetes in Brazil. Acta Diabetol. 2010;47(2):137-45.
Morisky DE, Green LW, Levine DM. Concurrent and Predictive Validity of a Self-Reported Measure of Medication Compliance. Med Care. 1986;24(1):67-74.
Nathan DM. The Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview. Diabetes Care . 2014;37(1):9-16.
Obreli-Neto PR, Guidoni CM, Baldoni AO, Pilger D, CruciolSouza JM, Gaeti-Franco WP, et al. Effect of a 36-month pharmaceutical care program onpharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm. 2011;33(4):642-649.
Peres HA, Freitas-Foss MC, Pereira LRL, Viana CM. New insights for the polypharmacy use in elderly with diabetes-an update about effect of education leve. J Endocrinol Diabetes. 2017;4(5):1-6.
Peres HA, Martinez EZ, Pereira LRL, Freitas-Foss MC. Age, the Number of Medicines Taken and Comorbidities are Associated with Changes of Fasting Blood Glucose Levels in Elderly Diabetics Taking Propranolol and Hydrochlorothiazide. J Bioanal Biomed. 2017;9(5):240-243.
Peres HA, Pereira LRL, Martinez EZ, Viana CM, Foss-Freitas MC. Heart failure is associated with non-adherence to pharmacotherapy in elderly with type 2 diabetes mellitus in public health system Brazilians. Diabetes Metab Syndr. 2019;13(2):939-946.
Peres HA, Pereira LRL, Martinez EZ, Viana CM, Foss-Freitas MC. Elucidating factors associated with non-adherence among Type 1 diabetes patients in primary care setting in Southeastern Brazil. Prim Care Diabetes . 2020;14(1):85-92. https://pubmed.ncbi.nlm.nih.gov/31262602/
» https://pubmed.ncbi.nlm.nih.gov/31262602/
Raehl CL, Bond CA, Woods T, Patry RA, Sleeper RB. Individualized drug use assessment in the elderly. Pharmacotherapy. 2002;22(10):1239-48.
Simard P, Presse N, Roy L, Dorais M, White-Guay B, Räkel A, et al. Persistence and compliance to oral diabetess: a population-based cohort study. Acta Diabetol . 2015;52(3):547-556.
Souza LCVFD, Kraemer GDC, Koliski A, Carreiro JE, Cat MNL, Lacerda LD, et al. Diabetic ketoacidosis as the initial presentation of type 1 diabetes in children and adolescents: epidemiological study in southern Brazil. Rev Paul Pediatr. 2020;38:e2018204.
Speight J, Holmes-Truscott E, Harvey DM, Hendrieckx C, Hagger VL, Harris SE, et al. Structured type 1 diabetes education delivered in routine care in Australia reduces diabetes-related emergencies and severe diabetes-related distress: The OzDAFNE program. Diabetes Res Clin Pract . 2016;112:65-72.
Tiv M, Viel JF, Mauny F, Eschwège E, Weill A, Fournier C, et al. Medication compliance in type 2 diabetes: The ENTRED study 2007, a French population-based study. PLoS One . 2012;7(3):e32412.
Tuomilehto J. The emerging global epidemic of type 1 diabetes. Curr Diab Rep. 2013;13(6):795-804.
World Health Organization. Global status report on noncommunicable diseases 2014. Genebra: WHO Library Cataloguing-in-Publication Data; 2014. 302 p.
Zhu VJ, Tu W, Marrero DG, Rosenman MB, Overhage JM. Race and medication compliance and glycemic control: findings from an operational health information exchange. AMIA Annu Symp Proc. 2011;2011:1649-57.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on line journal has open and free access.
